This trial is active, not recruiting.

Conditions diabetes, impaired glucose tolerance (igt), impaired fasting glucose (ifg), glucose intolerance
Treatment observational: no treatment involved
Sponsor Chinese University of Hong Kong
Start date November 2008
End date December 2018
Trial size 3000 participants
Trial identifier NCT00787215, ADF-2008-3


Hypothesis: There is a high rate of glucose intolerance among Hong Kong Chinese.

The investigators plan to screen Hong Kong Chinese from the community with oral glucose tolerance test (OGTT). The subjects will be referred from GP centers in the community and self-referred with public advertisement on this survey.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
observational: no treatment involved
observational: no treatment involved
observational: no treatment involved

Primary Outcomes

Glucose intolerance status by OGTT
time frame: 2 months

Secondary Outcomes

Glucose intolerance status predicted by Chinese University Diabetes Risk Score validated by OGTTT
time frame: 2 years

Eligibility Criteria

Male or female participants at least 12 years old.

Inclusion Criteria: - Hong Kong Chinese without history of diabetes Exclusion Criteria: - known diabetic patients

Additional Information

Official title A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese: Validation of the Chinese University Diabetes Screening Score
Principal investigator Gary Ko, MD
Trial information was received from ClinicalTrials.gov and was last updated in August 2015.
Information provided to ClinicalTrials.gov by Chinese University of Hong Kong.